<DOC>
<DOCNO>
EP-0003589
</DOCNO>
<TEXT>
<DATE>
19790822
</DATE>
<IPC-CLASSIFICATIONS>
<main>A61K-9/20</main> A61K-33/06 A61K-33/08 A61K-9/20 
</IPC-CLASSIFICATIONS>
<TITLE>
antacid tablet formulation.
</TITLE>
<APPLICANT>
wellcome foundgb<sep>the wellcome foundation limited<sep>the wellcome foundation limitedunicorn house 160 euston road p.o. box 129london nw1 2bpgb<sep>the wellcome foundation limited<sep>
</APPLICANT>
<INVENTOR>
gayst stephen<sep>harden david<sep>gayst, stephen<sep>harden, david<sep>gayst, stephen19 arthur streetdouble bay new south walesau<sep>harden, david25 sandhurst roadsidcup, kentgb<sep>gayst, stephen<sep>harden, david  <sep>gayst, stephen 19 arthur streetdouble bay new south walesau<sep>harden, david25 sandhurst roadsidcup, kentgb<sep>
</INVENTOR>
<ABSTRACT>
a dispersible tablet formulation comprising a conventional  antacid component in an amount of from 50 to 90%  by weight and a disintegrating agent having a swelling  capacity of between 5 and 100 ml/g and in an amount of  from 5 to 15% by weight.  
</ABSTRACT>
</TEXT>
</DOC>
